LCM
KNTE
Lynx1 Capital Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,981,106
| Closed | -$5.27M | – | 22 |
|
|
2024
Q1 | $5.27M | Sell |
1,981,106
-15,900
| -0.8% | -$42.3K | 1.36% | 11 |
|
|
2023
Q4 | $4.73M | Hold |
1,997,006
| – | – | 1.86% | 9 |
|
|
2023
Q3 | $2.8M | Sell |
1,997,006
-51,730
| -3% | -$72.4K | 1.85% | 10 |
|
|
2023
Q2 | $6.21M | Sell |
2,048,736
-165,514
| -7% | -$502K | 4.07% | 9 |
|
|
2023
Q1 | $13.8M | Buy |
2,214,250
+215,833
| +11% | +$1.35M | 11.54% | 4 |
|
|
2022
Q4 | $12.2M | Buy |
1,998,417
+323,740
| +19% | +$1.97M | 10.54% | 4 |
|
|
2022
Q3 | $20M | Hold |
1,674,677
| – | – | 18.05% | 3 |
|
|
2022
Q2 | $21.1M | Buy |
1,674,677
+982,169
| +142% | +$12.4M | 17.99% | 3 |
|
|
2022
Q1 | $7.8M | Buy |
+692,508
| New | +$7.8M | 7.24% | 6 |
|